Clinical Trial Update: IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous versus intra-arterial alteplase (Activase) in acute ischemic stroke with CTA-confirmed major vessel occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Ischemic Stroke | NA | Status: COMPLETED